India ships $683M in pharmaceutical products to Germany each year, making it the #8 export destination. Both countries track this trade: Eurostat import data confirms the scale.
$683M
Scale
India supplies $683M in pharmaceutical products to Germany each year — a substantial supply line of affordable medicine.
63%
Medicine
Primarily medicines (63%), supplemented by medicine ingredients and traditional & herbal.
3.1×
Trajectory
Rapid expansion: Germany's imports of Indian pharmaceutical products have grown 3.1× over the past decade, from $219M to $683M.
#8
Context
A top-10 export destination, and a key pharmaceutical market in Europe.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Germany — building trade and operational presence.
$634M
Ranking Basis
India's official export data (DGCIS, FY 2025–26) records $634M in pharmaceutical products to Germany — the figure behind the #8 ranking.
Additional pharmaceutical categories from DGCIS — APIs, surgical, herbal, and more
India also supplied $137M in active pharmaceutical ingredients
and bulk drugs to Germany in 2025 (India-reported, DGCIS).
The relationship flows both ways. German pharmaceutical companies are among the largest investors in India's health ecosystem — operating manufacturing plants, R&D centres, and clinical trial networks across the country.
Bayer
$55B global revenue
101,369 employees
Xarelto (Cardiovascular) · Eylea (Ophthalmology) · Mirena (Women's Health)
Boehringer Ingelheim
$29B global revenue
54,543 employees
JARDIANCE (Diabetes) · OFEV (Respiratory) · SPIRIVA (Respiratory)
Merck KGaA
$24B global revenue
64,243 employees
Erbitux (Oncology) · Glucophage (Diabetes) · Mavenclad (Neurology)